Journal
PARASITOLOGY
Volume 136, Issue 12, Pages 1445-1456Publisher
CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0031182009990515
Keywords
malaria; merozoite; MSP1; structure; antibody
Categories
Funding
- Medical Research Council [MC_U117532067] Funding Source: Medline
- MRC [MC_U117532067] Funding Source: UKRI
Ask authors/readers for more resources
Over the last 30 years, evidence has been gathered suggesting that merozoite Surface protein 1 (MSP1) is a target of protective immunity against malaria. In a variety of experimental approaches using in vitro methodology, animal models and sero-epidemiological techniques, the importance of antibody against MSP1 has been established but we are still finding Out what are the mechanisms involved. Now that clinical trials of MSP1 vaccines are underway and the early results have been disappointing, it is increasingly clear that we need to know more about the mechanisms of immunity, because a better understanding will highlight the limitations of Our current assays and identify the improvements required. Understanding the structure of MSP1 will help us design and engineer better antigens that are more effective than the first generation of vaccine candidates. This review is focused on the carboxy-terminus of MSP1.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available